Surgical treatment of lung cancer in patients with coronary artery surgery
https://doi.org/10.24884/0042-4625-2021-180-1-60-64
Abstract
The objective was to improve the surgical treatment tactics in patients with non-small cell lung cancer (NSCLC) and coronary heart disease (CHD), requiring myocardial revascularization.
Methods and materials. Two groups consisting of 24 patients operated on for NSCLC were examined. In one group, operations for NSCLC were performed in the second stage after coronary artery bypass grafting (CABG). Survival rates in both groups and factors influencing them were evaluated.
Results. The number of postoperative complications in both groups was comparable: 20.8 % in patients with CABG and 16.6 % in the group operated only for NSCLC. Indicators of relapse-free and overall survival did not differ significantly from each other (p=0.90 and p=0.95). Only the stage of the disease (p=0.009) and the implementation of complex cancer treatment in case of its necessity (p=0.035) had a reliably impact on the long-term results of the operation. The first stage of myocardial revascularization surgery did not affect the results of treatment (p=0.94), as well as the age of patients, the volume of performed surgery, the morphological picture of the tumor.
Conclusion. The staging approach to the treatment of patients with NSCLC and critical forms of CHD requiring myocardial revascularization is reliable, convenient and does not affect the long-term results of treatment.
About the Authors
A. V. Reshetov
North-Western State Medical University named after I.I. Mechnikov, Russia, St. Petersburg;
Russian Federation
Competing Interests:
Russian Federation
Reshetov Aleksey V. - Cand. of Sci. (Med.), Associate Professor of the Department of Phthisiopulmonology and Thoracic Surgery.
41, Kirochnaya str., Saint Petersburg, 191015
Competing Interests:
no conflict of interest
A. V. Elkin
North-Western State Medical University named after I.I. Mechnikov, Russia, St. Petersburg;
Russian Federation
Competing Interests:
Russian Federation
Elkin Aleksey V. - Dr. of Sci. (Med.), Professor, Head of the Department of Phthisiopulmonology and Thoracic Surgery.
Saint Petersburg
Competing Interests:
no conflict of interest
G. V. Nikolaev
National Medical Research Center named after V.A. Almazova, Russia, St. Petersburg
Russian Federation
Competing Interests:
Russian Federation
Nikolaev German V. - Cand. of Sci. (Med.), Head of the Research Laboratory of Transplantation and Thoracic Surgery.
Saint Petersburg
Competing Interests:
no conflict of interest
S. S. Stepanov
National Medical Research Center named after V.A. Almazova, Russia, St. Petersburg
Russian Federation
Competing Interests:
Russian Federation
Stepanov Sergei S. - Cardiac Surgeon.
Saint Petersburg
Competing Interests:
no conflict of interest
References
1. Ma X. C., Huang F., Zhang Z. et al. Lung cancer resection with concurrent off-pump coronary artery bypasses: safety and efficiency // J. Thorac. Dis. 2016;8(8):2038–2045.
2. Yeginsu A., Vayvada., Karademir B. C. et al. Combined Off-Pump Coronary Artery Bypass Grafting and Lung Resection in Patients with Lung Cancer Accompanied by Coronary Artery Disease // Braz. J. Cardiovasc. Surg. 2018;33(5):483–489.
3. Porkhanov V. A., Barbukhatti K. O., Kononenko V. B. et al. Simultaneous surgeries with concurrent lung cancer and heart ischemic disease // Grudnaya I Serdechno-Sosudistaya Khirurgiya. 2016;58(2):114–121. (In Russ).
4. Kanzaki R., Kimura T., Kawamura T. et al. Treatment of simultaneously discovered lung cancer and cardiovascular disease: a 20-year singleinstitution experience // Surg Today. 2017;47(6):726–732.
5. Tourmousoglou C. E., Apostolakis E., Dougenis D. Simultaneous occurrence of coronary artery disease and lung cancer: what is the best surgical treatment strategy // Interact. Cardiovasc. Thorac. Surg. 2014;19(4):673–681.
6. Miyamoto N., Kishimoto N., Suehiro S. et al. Strategies for lung cancer with ischemic heart disease // Kyobu Geka. 2015;68(4):279–285.
7. Bablekos G. D., Analitis A., Michaelides S. A. et al. Management and postoperative outcome in primary lung cancer and heart disease comorbidity: a systematic review and meta-analysis // Ann. Transl. Med. 2016;4(11):213.
8. Davydov M. I., Akchurin R. S., Gerasimov S. S., Dzemeshkevich S. L., Brandt Ia. B., Dolgov I. M., Shestopalova I. M. Sochetannoe khirurgicheskoe lechenie onkologicheskih bolnih s konkuriruiuschmi serdechno-sosudistimi zabolevaniami pri opuholevih zabolevaniah legkih. Khirurgia. 2010;(8):4–10. (In Russ.).
9. Dyszkiewicz W., Jemielity M., Piwkowski C. et al. The early and late results of combined off-pump coronary artery bypass grafting and pulmonary resection in patients with concomitant lung cancer and unstable coronary heart disease // Eur. J. Cardiothorac. Surg. 2008;34(3):351–355.
10. Darwazah A. K., Osman M., Sharabati B. Use of off-pump coronary artery bypass surgery among patients with malignant disease // J. Card. Surg. 2010;25(1):1–4.
Supplementary files
Review
For citations:
Reshetov A.V., Elkin A.V., Nikolaev G.V., Stepanov S.S. Surgical treatment of lung cancer in patients with coronary artery surgery. Grekov's Bulletin of Surgery. 2021;180(1):60-64. (In Russ.) https://doi.org/10.24884/0042-4625-2021-180-1-60-64
Views:
519
Email this article 